Jane Street’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$923K Buy
+80,500
New +$1.12M ﹤0.01% 6645

Other funds holding CLYM

Jane Street's CLYM Position: Q3 2026 in Review

Jane Street increased its Climb Bio (CLYM) stake by 140% in Q3 2026, buying an estimated $2.58M and bringing the position to 316,655 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4198.

Jane Street first reported a position in CLYM in Q3 2024 and has held it in 7 quarters since. 128 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • Jane Street held 316,655 shares of Climb Bio worth $3.63M as of Q3 2026.
  • Jane Street bought 184,894 Climb Bio shares in Q3 2026, an estimated $2.58M.
  • Climb Bio made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4198 holding.
  • Jane Street first reported a position in Climb Bio in Q3 2024 and has held it in 7 quarters since.
  • 128 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.